Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025, Jan 2026 and Mar 2026.
- Largest single sale: $4.0M (65,000 shares) of Xenon Pharmaceuticals Inc. on Mar 9, 2026. Filing
- Last sale before this period: Oct 1, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | President & CEO, Director | Nov 4, 2014 | Oct 1, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 30, 2026, Xenon Pharmaceuticals Inc.: bought 30,000 shares for $1.1M. 1 filing: 1
- Mar 13, 2026, Xenon Pharmaceuticals Inc.: sold 7,308 shares for $404K, under a disclosed plan. 1 filing: 1
- Mar 12, 2026, Xenon Pharmaceuticals Inc.: 12,500 shares vested. 1 filing: 1
- Mar 10, 2026, Xenon Pharmaceuticals Inc.: sold 11,269 shares for $677K, under a disclosed plan. 1 filing: 1
- Mar 9, 2026, Xenon Pharmaceuticals Inc.: sold 270,000 shares for $16.3M, under a disclosed plan; 270,000 shares acquired by exercising options; 20,000 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.